SOURCE-LINKED INTELLIGENCE

Intelligent Ingestible Devices for Gastrointestinal Therapeutics, Diagnosis or Intervention.

CORDIS · observation · Publication date unknown

ly delivered miniaturised devices. This ingestible technology has the potential to unlock significant advances across the medical sciences, whether it is enhanced diagnosis through the application of artificial intelligence or the integration of multiple sensors into these devices, surgery through less invasive biopsy or treatment through targeted drug delivery direct to the site of interest or the development of therapeutic form factors that can safely reside within the gastrointestinal tract for extended periods, removing the need for daily treatment and improving the adherence of patients to the treatment regimen. However, to achieve this potential, several scientific challenges must be addressed. These include needing more accurate localisation, improving our ability to know where the devices are along the gastrointestinal tract at any time for better treatment and repeated diagnosis. The second challenge is the need to integrate more advanced diagnostic and therapeutic technology, which is vital for more accurate identification and treatment of pathology. The third challenge is

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

2686665.6

unit

EUR